MODULATION OF AFFINITY AND DENSITY OF LTB4 RECEPTORS ON GUINEA-PIG LUNG MEMBRANES BY DIVALENT-CATIONS AND GUANINE-NUCLEOTIDES

被引:8
作者
FALCONE, RC [1 ]
AHARONY, D [1 ]
机构
[1] ICI PHARMACEUT GRP, DEPT PHARMACOL, WILMINGTON, DE 19897 USA
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1991年 / 206卷 / 04期
关键词
H-3]LEUKOTRIENE-B4; LEUKOTRIENE-B4; LEUKOTRIENE RECEPTORS; GUANINE NUCLEOTIDES; (GUANYL-5'-YL-IMIDODIPHOSPHATE)GPPNHP DIVALENT CATIONS;
D O I
10.1016/0922-4106(91)90118-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the mechanism by which guanine nucleotides and divalent cations modulate the affinity and apparent density of high-affinity receptors for Leukotriene B4 (LTB4) on guinea pig lung membranes (GPLM). Divalent cations (Mg2+ = Ca2+ > Mn2+) stimulated, whereas EDTA inhibited (IC50 = 0.31 +/- 0.08 mM) binding of [H-3]LTB4. Saturation analysis demonstrated that omission of divalent cations caused a two-fold reduction in apparent site density, (B(max) = 297 +/- 24 fmol/mg protein vs. 149 +/-21 fmol/mg protein, P < 0.01, for control and EDTA-treated respectively), but no significant change in receptor affinity (K(D) = 0.67 +/- 0.16 nM and 1.01 +/- 0.19 nM, P > 0.05). Competition experiments with LTB4 and the low-affinity (K(i) = 165 nM) competitive LTB4-antagonist U75302, also demonstrated that EDTA caused a significant reduction (1.7 and 3.6 fold, P < 0.05 and P < 0.01, respectively), in affinity to both ligands. In the same experiments, the guanine nucleotide analog GppNHp also reduced the affinity for LTB4 and U75302, similar to that observed with EDTA, suggesting that removal (Mg2+), or addition (GppNHp), of allosteric modulators of G-protein(s), causes reduction in receptor affinity. Saturation experiments also demonstrated that GppNHp, or GTP(gamma-S), caused a significant reduction (40-50%) in receptor density. A larger reduction in affinity for U75302 (3- to 3.6-fold) than for LTB4 (1.7-fold) was induced by EDTA as well as GTP analogs. The data suggest that LTB4 receptors on GPLM can undergo a transition between a G-protein coupled, high-affinity state, to an uncoupled state with fewer number of receptors, that possess lower affinity for ligands.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 17 条
  • [1] AHARONY D, 1989, J PHARMACOL EXP THER, V248, P581
  • [2] AHARONY D, 1988, ANN NY ACAD SCI, V524, P162
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [5] CRISTOL JP, 1988, J PHARMACOL EXP THER, V247, P1199
  • [6] FALCONE RC, 1990, J PHARMACOL EXP THER, V255, P565
  • [7] LEUKOTRIENE-B, A POTENT CHEMOKINETIC AND AGGREGATING SUBSTANCE RELEASED FROM POLYMORPHONUCLEAR LEUKOCYTES
    FORDHUTCHINSON, AW
    BRAY, MA
    DOIG, MV
    SHIPLEY, ME
    SMITH, MJH
    [J]. NATURE, 1980, 286 (5770) : 264 - 265
  • [8] G-PROTEINS CONTROL DIVERSE PATHWAYS OF TRANSMEMBRANE SIGNALING
    FREISSMUTH, M
    CASEY, PJ
    GILMAN, AG
    [J]. FASEB JOURNAL, 1989, 3 (10) : 2125 - 2131
  • [9] GOLDMAN DW, 1985, J IMMUNOL, V135, P525
  • [10] GOLDMAN DW, 1982, J IMMUNOL, V129, P1600